Analystreport

Horizon Therapeutics PLC (NASDAQ: HZNP) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $110.00 price target on the stock.

Horizon Therapeutics Public Limited Company - Ordinary Shares  (HZNP) 
Last horizon therapeutics public limited company - ordinary shares earnings: 2/26 07:00 am Check Earnings Report